English Emily's most recent trade in Cartesian Therapeutics Inc was a trade of 71,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cartesian Therapeutics Inc | Emily English | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 71,000 | 71,000 | - | - | Employee Stock Option (right to buy) | |
| Cartesian Therapeutics Inc | Emily English | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 24,000 | 94,226 (0%) | 0% | 0 | Common Stock | |
| Cartesian Therapeutics Inc | Emily English | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Dec 2025 | 7,500 | 19,369 | - | - | Stock Option (Right to Buy) | |
| Cartesian Therapeutics Inc | Emily English | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.30 per share. | 30 Dec 2025 | 7,500 | 70,226 (0%) | 0% | 3.3 | 24,750 | Common Stock |
| Cartesian Therapeutics Inc | Emily English | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Nov 2025 | 7,500 | 26,869 | - | - | Stock Option (Right to Buy) | |
| Cartesian Therapeutics Inc | Emily English | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.30 per share. | 28 Nov 2025 | 7,500 | 62,726 (0%) | 0% | 3.3 | 24,750 | Common Stock |
| Cartesian Therapeutics Inc | Emily English | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2025 | 7,500 | 34,369 | - | - | Stock Option (Right to Buy) | |
| Cartesian Therapeutics Inc | Emily English | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.30 per share. | 12 May 2025 | 7,500 | 55,226 (0%) | 0% | 3.3 | 24,750 | Common Stock |
| Cartesian Therapeutics Inc | Emily English | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.30 per share. | 15 Apr 2025 | 7,500 | 47,726 (0%) | 0% | 3.3 | 24,750 | Common Stock |
| Cartesian Therapeutics Inc | Emily English | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2025 | 7,500 | 41,869 | - | - | Stock Option (Right to Buy) | |
| Cartesian Therapeutics Inc | Emily English | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 16.83 per share. | 03 Jan 2025 | 906 | 40,226 (0%) | 0% | 16.8 | 15,250 | Common Stock |
| Cartesian Therapeutics Inc | Emily English | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 16.72 per share. | 03 Jan 2025 | 891 | 41,132 (0%) | 0% | 16.7 | 14,899 | Common Stock |
| Cartesian Therapeutics Inc | Emily English | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 47,400 | 47,400 | - | - | Employee Stock Option (right to buy) | |
| Cartesian Therapeutics Inc | Emily English | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 16,100 | 42,023 (0%) | 0% | 0 | Common Stock | |
| Cartesian Therapeutics Inc | Emily English | SVP, Head of Manufacturing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Dec 2024 | 7,650 | 49,369 | - | - | Stock Option (Right to Buy) | |
| Cartesian Therapeutics Inc | English Emily | SVP, Head of Manufacturing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.30 per share. | 26 Dec 2024 | 7,650 | 25,923 (0%) | 0% | 3.3 | 25,245 | Common Stock |